• OPEN AN ACCOUNT
Indian Indices
Sensex
73,341.11 217.28
( 0.30%)
Global Indices
Nasdaq
52,230.09 -658.89
(-1.25%)
Dow Jones
7,644.13 -40.30
(-0.52%)
Hang Seng
62,584.98 -322.86
(-0.51%)
Nikkei 225
10,670.63 -54.40
(-0.51%)
Forex
USD-INR
94.61 0.10
(0.11%)
EUR-INR
106.18 0.08
(0.07%)
GBP-INR
126.70 0.19
(0.15%)
JPY-INR
0.60 0.00
(0.70%)

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
78871
INE0L4V01013
18.604918
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VILINBIO
40.44
77.7
EPS(TTM)
Face Value()
Div & Yield %
1.26
10
0
 

veedol corporation ltd
Hindustan Composites consolidated net profit rises 92.75% in the March 2026 quarter
Apr 24,2026
Net profit of Hindustan Composites rose 92.75% to Rs 11.70 crore in the quarter ended March 2026 as against Rs 6.07 crore during the previous quarter ended March 2025. Sales rose 17.60% to Rs 104.84 crore in the quarter ended March 2026 as against Rs 89.15 crore during the previous quarter ended March 2025.

For the full year,net profit declined 11.11% to Rs 31.11 crore in the year ended March 2026 as against Rs 35.00 crore during the previous year ended March 2025. Sales rose 15.36% to Rs 375.01 crore in the year ended March 2026 as against Rs 325.08 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales104.8489.15 18 375.01325.08 15
OPM %15.5818.21 -14.7918.09 -
PBDT16.6925.03 -33 55.5867.79 -18
PBT13.5222.44 -40 43.6057.46 -24
NP11.706.07 93 31.1135.00 -11